Columbus Circle Investors’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$11.1M Buy
+7,797
New +$8.32M 0.49% 86
2020
Q3
– Sell
-1,450
Closed -$1.01M – 171
2020
Q2
$1.01M Buy
+1,450
New +$837K 0.04% 140
2020
Q1
– Sell
-2,911
Closed -$1.83M – 150
2019
Q4
$1.83M Buy
2,911
+461
+19% +$225K 0.08% 134
2019
Q3
$821K Buy
+2,450
New +$785K 0.03% 144

Other funds holding CDLX

Columbus Circle Investors's CDLX Position: Q4 2020 in Review

Columbus Circle Investors opened a new position in Cardlytics (CDLX) in Q4 2020: 7,797 shares worth $11.1M. The stake represents 0.49% of the portfolio and ranks #86 among its holdings. This is a return to the name: Columbus Circle Investors previously reported a position in CDLX as recently as Q2 2020.

Columbus Circle Investors first reported a position in CDLX in Q3 2019 and has held it in 4 quarters since. 195 funds tracked by Wall St. Rank hold CDLX as of Q4 2020.

  • Columbus Circle Investors held 7,797 shares of Cardlytics worth $11.1M as of Q4 2020.
  • Cardlytics was a new Columbus Circle Investors position in Q4 2020.
  • Cardlytics made up 0.49% of Columbus Circle Investors's portfolio in Q4 2020, its #86 holding.
  • Columbus Circle Investors first reported a position in Cardlytics in Q3 2019 and has held it in 4 quarters since.
  • 195 funds tracked by Wall St. Rank held Cardlytics as of Q4 2020.

Based on Columbus Circle Investors's 13F filing for Q4 2020, filed 20 Jan 2021.